New Research Poster 6 (open)
New Research Posters Session 6

Saturday, October 31, 2015: 10:00 AM-12:30 PM
 
6.1
Epigenetic Modifications Induced by Maternal Smoking During Pregnancy in Children With ADHD
Venkat Bhat, MD McGill University, Montreal, QC
Natalie Grizenko, MD Douglas Mental Health University Institute, Montreal, QC
Ridha Joober, MD McGill University, Montreal, QC
Sarojini Sengupta, PhD Douglas Mental Health University Institute, Verdun, QC
 
6.2
Mental Health Service Use and Psychotropic Medication Use Among Puerto Rican Youth With Disruptive Behavior Disorders
Maria Carolina Zerrate, MD New York Presbyterian Hospital Columbia University, New York, NY
Maria A. Ramos-Olazagasti, PhD Columbia University and New York State Psychiatric Institute, New York, NY
Glorisa Canino, PhD University of Puerto Rico, Rio Piedras, PR
Hector R. Bird, MD Columbia University Medical Center, New York, NY
Cristiane S. Duarte, PhD Columbia University Medical Center, New York, NY
 
6.3
Psychiatric Comorbidities and Substance Use in Young Adult Patients With Dermatologic Conditions
Cindy E. Parra, BA Weill Cornell Medical College, New York, NY
Susan Samuels, MD New York Psychiatric Institute and Columbia University Medical College, New York, NY
 
6.4
Barriers That Delay the Assessment and Treatment of ADHD in Children and Adolescents
E. Michelle Allison, BA University of Illinois at Chicago, Chicago, IL
Marilyn Griffin, MD University of Illinois at Chicago, Chicago, IL
 
6.5
Arousal and Cognitive Performance in ADHD: A Pilot Pupillometry Study
Argelinda Baroni, MD The NYU Child Study Center and NYU Langone Medical Center, New York, NY
Emma L. Ducca, BA NYU Langone Medical Center, New York, NY
Alessandro Francia The NYU Child Study Center, New York, NY
Indu Ayappa, PhD NYU Langone Medical Center, New York, NY
David M. Rapoport, MD NYU Langone Medical Center, New York, NY
F. Xavier Castellanos, MD The NYU Child Study Center, New York, NY
 
6.6
Examination of White Matter Tract Abnormalities in Pediatric Posttraumatic Stress Disorder
Nathaniel J. Kohlenberg, BA University of Wisconsin, Madison School of Medicine and Public Health, Madison, WI
Do P.M. Tromp, MS University of Wisconsin, Madison Neuroscience Training Program, Madison, WI
Christy A. Olson, PhD University of Wisconsin, Madison School of Medicine and Public Health, Madison, WI
Taylor J. Keding, BS University of Wisconsin, Madison School of Medicine and Public Health, Madison, WI
Ryan Herringa, MD, PhD University of Wisconsin, Madison School of Medicine and Public Health, Madison, WI
 
6.7
Improving Current Therapeutic Models for Families Affected By Substance Abuse
George Gianakakos, MS University of Illinois at Chicago College of Medicine, Chicago, IL
 
6.8
Predictors of Missed Child Psychiatry Appointments
Michael Adragna, MD University at Buffalo, Buffalo, NY
 
6.9
Pediatric Akathisia in an Outpatient Setting
Fernando Espi Forcen, MD Memorial Sloan Kettering, New York, NY
Karam Radwan, MD University of Chicago, Chicago, IL
Kate Keenan, PhD University of Chicago, Chicago, IL
Alan Arauz, MD Mount Sinai St. Luke's Roosevelt, New York, NY
 
6.10
Rural Community Child and Adolescent Psychiatry Experience in an Urban Psychiatry Residency Program Via Telemedicine: Residents' Perspectives
Pravesh Sharma, MD Texas Tech University Health Sciences Center, Lubbock, TX
Ankit A. Parmar, MD Texas Tech University Health Sciences Center, Lubbock, TX
Deepti Vats, MD Texas Tech Health Science Center, Lubbock, TX
Manish Aligeti, MD Texas Tech University Health Sciences Center, Lubbock, TX
Billy Philips Jr., MPH, PhD Texas Tech Health Science Center, Lubbock, TX
Terry McMahon, MD Texas Tech Health Science Center, Lubbock, TX
 
6.11
Atomoxetine Monotherapy Compared With Combination Therapy in Children and Adults for Treatment of Four Symptom Domains of ADHD: A Real-World Retrospective Chart Study
David Clemow, PhD Eli Lilly and Company, Indianapolis, IN
Oren Mason, MD Attention MD, Grand Rapids, MI
Elias Sarkis, MD Sarkis Family Psychiatry, Gainesville, FL
Dustin D. Ruff, PhD Eli Lilly and Company, Indianapolis, IN
Andre Araujo, PhD Lilly USA, LLC, Indianapolis, IN
 
6.12
Factors Associated With Accidental Injuries in Children With ADHD
Amanda J. Connolly, BS Monash University, Clayton Australia
Joanne Fielding, PhD Monash University, Clayton Australia
Nicole Papadopoulos, PhD Deakin University, Burwood Australia
Jennifer McGinley, PhD University of Melbourne, Melbourne Australia
Anna T. Murphy, PhD Clinical Research Centre for Movement Disorders and Gait, Monash Health, Cheltenham Australia
Nicole Rinehart, PhD Deakin University, Burwood Australia
 
6.13
Medication Treatment for ADHD Among U.S. Children With Special Health Care Needs
Melissa Danielson, MS Centers for Disease Control and Prevention, Atlanta, GA
Susanna Visser, DrPH Centers for Disease Control and Prevention, Atlanta, GA
Rebecca H. Bitsko, PhD Centers for Disease Control and Prevention, Atlanta, GA
Stephen Blumberg, PhD Centers for Disease Control and Prevention, Hyattsville, MD
Joseph Holbrook, PhD Centers for Disease Control and Prevention, Atlanta, GA
Steven P. Cuffe, MD University of Florida College of Medicine, Jacksonville, FL
 
6.14
Correlates of Lifetime Victimization Trauma in a Clinical Sample of Adolescents With ADHD
William Burleson Daviss, MD Dartmouth-Hitchcock Medical Center, Lebanon, NH
Rasim Somer Diler, MD Western Psychiatric Institute and Clinic, Pittsburgh, PA
 
6.15
A Study on Cognitive Remediation in Children With ADHD and Pediatric Bipolar Disorder
Liza Dominguez-Colman, MD University of Illinois at Chicago, Chicago, IL
Nidhi Trivedi, MS University of Illinois at Chicago, Chicago, IL
Nadine Kahl, BS Institute for Juvenile Research, Cognitive Neuroscience Center, Pediatric Brain Research And Intervention Center, Chicago, IL
Manhar Patel, MD University of Illinois at Chicago, Chicago, IL
Scott A. Langenecker, PhD University of Illinois at Chicago, Chicago, IL
Alessandra M. Passarotti, PhD University of Illinois at Chicago, Chicago, IL
 
6.16
Association of DAT1 Gene and Clock Gene (T3111C) Genotypes, Family Functioning, Parental Psychopathology, and Treatment Response in ADHD Adolescents
Diana Guizar, MSC Universidad Nacional Autónoma de México, Mexico Mexico
Francisco De la PeÒa, MD Instituto Nacional de Psiquiatría Ramon de la Fuente Muñiz, Mexico City Mexico
Lino Palacios, MD, MS Instituto Nacional de Psiquiatria, Mexico Mexico
 
6.17
The Correlation Between Cognitive and Movement Shifting and Brain Activity in Adolescents With ADHD
Doug Hyun Han, DrPH Chung Ang University Hospital, Seoul South Korea
Gi Jung Hyun Chung Ang University Hospital, Seoul South Korea
Jeongha Park Chung Ang University Hospital, Seoul South Korea
 
6.18
The Management of ADHD in Adolescents in Primary Care
Katie L. Hoeveler, MD Children's Hospital of Philadelphia, Philadelphia, PA
Thomas Power, PhD Children's Hospital of Philadelphia, Philadelphia, PA
 
6.19
Exploratory Dose-Escalation Study of NFC-1 in ADHD Adolescents With Glutamatergic Gene Network Variants
Grace Jones, DO Temple University Hospital, Philadelphia, PA
Nilsa Dejesus-Rosario, MD Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA
Charlly Kao, PhD The Children's Hospital of Philadelphia, Philadelphia, PA
Alexander Ambrosini University of Pennsylvania, Philadelphia, PA
Lene Larsen, PhD Private Practice, Haverford, PA
Rosetta Chiavacci, RN The Children's Hospital of Philadelphia, Philadelphia, PA
Angela Pallotto, RN Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA
Christine Kurian, BA Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA
Kanani Titchen, MD duPont Hospital for Children, Sidney Kimmel Medical College at Thomas Jefferson University, Wilmington, DE
Brian Sykes, MD duPont Hospital for Children, Sidney Kimmel Medical College at Thomas Jefferson University, Wilmington, DE
Walter Kraft, MD Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA
Hakon Hakonarson, MD The Children's Hospital of Philadelphia; University of Pennsylvania, Philadelphia, PA
Josephine Elia, MD duPont Hospital for Children, Sidney Kimmel Medical College at Thomas Jefferson University, Wilmington, DE
 
6.20
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Fixed-Dose Study Evaluating the Safety and Tolerability of a Single Administration of MDX (Metadoxine Extended Release) in Adolescents With Predominantly Inattentive ADHD
Iris Manor, MD Geha MHC, Petach-Tiqva Israel
Eran Harary, MD Alcobra Pharma, Tel Aviv Israel
Jonathan Rubin, MD, MBA Alcobra Pharma, Philadelphia, PA
Yaron Daniely, MBA, PhD Alcobra Pharma, Tel Aviv Israel
 
6.22
Childhood ADHD and Socioeconomic Status: Accounting for the Impact that Social Disadvantage Has on Diagnosis and Symptom Severity
Lindsay Miller, BS Oregon Health & Science University, Portland, OR
Jessica Tipsord, PhD Oregon Health & Science University, Portland, OR
Joel Nigg, PhD Oregon Health & Science University, Portland, OR
 
6.23
Altered Functional Brain Networks in ADHD
Iman Mohammad-Rezazadeh, PhD University of California, Los Angeles, Los Angeles, CA
Joseph Jurgiel, BS University of California, Los Angeles, Los Angeles, CA
Kelly Tung, BS 1440 Veteran Ave, Los Angeles, CA
Joseph O'Neill, PhD University of California, Los Angeles, Los Angeles, CA
Jennifer Levitt, MD University of California, Los Angeles, Los Angeles, CA
Sandra K. Loo, PhD UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA
 
6.24
The Use of Psychoeducational Group Therapy Within a Pediatric Residency Continuity Clinic as a Novel Treatment Approach for Children With ADHD
GenaLynne Mooneyham, MD Indiana University, Indianapolis, IN
Dorota Szczepaniak, MD Indiana University, Indianapolis, IN
Paula Sullivan, PhD Indiana University, Indianapolis, IN
Amy Pottenger, BA Indiana University School of Medicine, Indianapolis, IN
Nerissa S. Bauer, MD Indiana University, Indianapolis, IN
 
6.25
Effect of Methylphenidate HCl Extended-Release Capsules on Sleep: Data From the Pivotal Trials
Margaret D. Weiss, MD, BS, FRCPC, MS, PhD University of British Columbia, West Vancouver, BC
Judith Owens, MD, MPH Boston Children's Hospital and Harvard Medical School, Boston, MA
Earl Nordbrock, PhD Rhodes Pharmaceuticals L.P., Coventry, RI
Sharon Wigal, PhD AVIDA Inc., Newport Beach, CA
Wei-Wei Chang, PhD NuTec Incorporated, Boston, MA
Robert Kupper, PhD Rhodes Pharmaceuticals L.P., Coventry, RI
Akwete Lex Adjei, PhD Rhodes Pharmaceuticals L.P., Coventry, RI
Ann Catherine Childress, MD Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas, NV
 
6.26
Modeling Treatment Response in ADHD Among Children and Adolescents in the Texas Medicaid Population
Chanhyun Park, MS University of Texas at Austin, Austin, TX
Regina Grebla, PhD Shire Development, LLC, Wayne, PA
Kristin M. Richards, PhD University of Texas at Austin, Austin, TX
Juliana Setyawan, MS, PharmD Shire, Wayne, PA
Esmond D. Nwokeji, PhD University of Texas at Austin, Austin, TX
Manjiri Pawaskar, PhD Shire Development, LLC, Wayne, PA
M. Haim Erder, PhD Shire Development, LLC, Wayne, PA
Kenneth A. Lawson, PhD University of Texas at Austin, Austin, TX
 
6.27
Prevalence of ADHD in the Population of Minors in the Protection System
Javier San Sebasti·n Sr., MD Hospital Universitario Ramón y Cajal, Madrid Spain
Pablo Jodra, PsyD Universidad Autónoma de Madrid, Madrid Spain
Carlos del Amo, MD Fundación Internacional O´Belén, Azuqueca de Henares Spain
Eugenia Giraudo, PsyD Fundación Internacional O´Belén, Azuqueca de Henares Spain
 
6.28
Metadoxine: A Novel Pro-Cognitive Drug Modulating the Gamma-Aminobutyric Acid Ergic System for Treatment of Cognitive Disorders
Johanna Schumann, PhD Alcobra Pharma, Tel Aviv Israel
Jonathan Rubin, MD, MBA Alcobra Pharma, Philadelphia, PA
Yaron Daniely, MBA, PhD Alcobra Pharma, Tel Aviv Israel
Lee Crossman, BS Covance Laboratories Limited, Harrogate United Kingdom
Anne Marie Hernier, BS Porsolt Laboratory, Le Genest-Saint-Isle France
 
6.29
ADHD Subtypes and Pharmacotherapy: Risk of Substance Use Among U.S. Adolescents
Navneet Upadhyay, MS University of Houston, Houston, TX
Hua Chen, MD University of Houston, Houston, TX
Vinod Bhatara, MD Sanford School of Medicine, Sioux Falls, SD
Osaro Mgbere, PhD Houston Health & Human Services, Houston, TX
Rajender R. Aparasu, PhD University of Houston, Houston, TX
 
6.30
Factors Related to Executive Functioning Maintenance of Response and Relapse in Patients Upon Discontinuation of Long Term Atomoxetine
Himanshu P. Upadhyaya, MD Eli Lilly and Company, Bellaire, TX
Lenard Adler, MD New York University School of Medicine, New York, NY
Mary V. Solanto, PhD NYU Langone Medical Center, New York, NY
Rodrigo Escobar, MD Eli Lilly and Company, Madrid Spain
Sarah Lipsius, MS inVentiv Health, Ann Arbor, MI
 
6.31
Working Memory and Negative Affect Mediate Increased Suicidal Ideation in Childhood ADHD
Brian W. Bauer, BA Oregon Health & Science University, Portland, OR
Joel Nigg, PhD Oregon Health & Science University, Portland, OR
Sarah Karalunas, PhD Oregon Health & Science University, Portland, OR
 
6.32
The Relative Bioavailability and Single-Dose Pharmacokinetics of a Novel Extended-Release Chewable Tablet of Methylphenidate Compared With Immediate-Release Methylphenidate Chewable Tablet in Healthy Volunteers
Richat Abbas, PhD Pfizer, Inc., New York, NY
Donna Palumbo, PhD Pfizer, Inc., New York, NY
Faith Walters, PharmD Pfizer, Inc., New York, NY
Heidi Belden, PharmD Pfizer, Inc., Plymouth, MA
Sally Berry, MD, PhD NextWave Pharmaceuticals, Titusville, NJ
 
6.33
Association Between SNAP-25 Gene Polymorphism and ADHD: A Meta-Analysis
Chuanzhong Ye, MD University of Miami Miller School of Medicine and Jackson Health System, Miami, FL
Zhijian Hu, PhD Fujian Medical University, Fujian China
Evan Wu, MD University of Miami Miller School of Medicine, Miami, FL
Xiaolu Yang, MS Fujian Medical University, Fujian China
Zhihong Guo, MD University of Miami Miller School of Medicine and Jackson Health System, Miami, FL
Radu V. Saveanu, MD University of Miami Miller School of Medicine and Jackson Health System, Miami, FL
 
6.34
Preventing Child and Adolescent Anxiety Disorders: An Overview of Systematic Reviews
Kathryn J. Bennett, PhD McMaster University, Hamilton, ON
Katharina Manassis, MD University of Toronto, Pickering, ON
Stephanie J. Duda, MSC McMaster University, Hamilton, ON
Alexa Bagnell, MD IWK Health Centre, Halifax, NS
Gail A. Bernstein, MD University of Minnesota, Minneapolis, MN
Elizabeth Jane Garland, MD BC Children's Hospital, Vancouver, BC
Lynn D. Miller, PhD University of British Columbia, Vancouver, BC
Amanda S. Newton, PhD University of Alberta, Edmonton, ON
Pamela Wilansky, PhD Ontario Shores Centre for Mental Health Sciences, Whitby, ON
 
6.35
Treating Child and Adolescent Anxiety Effectively: Overview of Systematic Reviews
Kathryn J. Bennett, PhD McMaster University, Hamilton, ON
Katharina Manassis, MD University of Toronto, Pickering, ON
Stephanie J. Duda, MSC McMaster University, Hamilton, ON
Alexa Bagnell, MD IWK Health Centre, Halifax, NS
Gail A. Bernstein, MD University of Minnesota, Minneapolis, MN
Elizabeth Jane Garland, MD BC Children's Hospital, Vancouver, BC
Lynn D. Miller, PhD University of British Columbia, Vancouver, BC
Amanda S. Newton, PhD University of Alberta, Edmonton, ON
Lehana Thabane, PhD McMaster University, Hamilton, ON
Pamela Wilansky, PhD Ontario Shores Centre for Mental Health Sciences, Whitby, ON
 
6.36
Coronary Distensibility Index is Impaired in Posttraumatic Stress Disorder With Childhood Trauma Exposure
Naser Ahmadi, MD, PhD UCLA Kern Medical Center, Bakersfield, CA
Matthew Budoff, MD University of California, Los Angeles, Torrance, CA
Abdolreza Saadabadi, MD UCLA Kern Medical Center, Bakersfield, CA
Garth Olango, MD, PhD UCLA Kern Medical Center, Bakersfield, CA
Mohammed Molla, MD UCLA Kern Medical Center, Bakersfield, CA
 
6.37
Trauma in an Urban Child and Adolescent Psychiatry Inpatient Service: Challenges of Identification, Service Provision, and Care
Shama Patel, MD SUNY Downstate Medical Center, Brooklyn, NY
Karen Forbes, PsyD SUNY Downstate Medical Center, Brooklyn, NY
Seanna-Kaye Denham, PhD SUNY Downstate Medical Center, Brooklyn, NY
Furqan Nusair, MD SUNY Downstate Medical Center, Brooklyn, NY
Isabelle Bollendorf, BA SUNY Downstate Medical Center, Brooklyn, NY
 
6.38
FKBP5 Polymorphisms in Puerto Rican Youth Exposed to Trauma
Nuria A. SabatÈ, MD Ponce Health Sciences University School of Medicine, Ponce, PR
James Porter, PhD Ponce Health Sciences University School of Medicine, Ponce, PR
Elsa B. Cardalda, PhD Research Consultant, Ponce, PR
Pedro A. Castaing, MD Ponce Health Sciences University School of Medicine, Ponce, PR
Nadya PÈrez, MPH Ponce Health Sciences University School of Medicine, Ponce, PR
 
6.39
Psychiatric Symptoms and Suicidality in a Sample of Gender Dysphoric Youth Presenting to a Newly Established Multidisciplinary Program: Gender Education and Care Interdisciplinary Support Within a Pediatric Medical Setting
Meredith R. Chapman, MD University of Texas Southwestern Medical Center, Dallas, TX
Jennifer Hughes, PhD University of Texas Southwestern Medical Center, Dallas, TX
Julie Long-Sherrod, PhD Children's Health, Children's Medical Center, Dallas, TX
Ximena Lopez, MD University of Texas Southwestern Medical Center, Dallas, TX
Bonnie Jenkins, LCSW Children's Health, Children's Medical Center, Dallas, TX
 
6.41
Means Restriction Education for Adolescent Suicide Prevention: A Quality Improvement Project of the Children's Hospital Colorado (CHCO) Psychiatric Emergency Service
Amy Becker, MD University of Colorado, Denver, CO
Catherine Barber, MPA Harvard Injury Control Research Center, Boston, MA
Douglas K. Novins, MD University of Colorado Denver, Aurora, CO
Carol Runyan, PhD Colorado School of Public Health, Program for Injury Prevention, Education and Research, Aurora, CO
Sara Brandspigel, MPH Colorado School of Public Health, Program for Injury Prevention, Education and Research, Aurora, CO
Jarrod Hindman, MS Colorado Department of Public Health and the Environment, Denver, CO
Dru Hunter, LCSW Children's Hospital Colorado, Aurora, CO
 
6.42
Stress and Coping Strategies in Students of the School of Medicine at the Autonomous University of the State of Mexico
Jesus Bermeo Sr., MD Universidad Autonoma del Estago del Mexico, Toluca Mexico
Blanca Guadalupe Alvarado, PhD Universidad Autonoma del Estago del Mexico, Toluca Mexico
Elizabeth Landeros, MD Asociacion Mexicana de Psiquiatria Infantil, A.C., Toluca Mexico
Sandra Gutierrez Universidad Autonoma del Estago del Mexico, Toluca Mexico
 
6.44
A 15-Year Follow-Up Study of Former Inpatients in Child and Adolescent Psychiatry: A Qualitative Study
Bjˆrn A. Johansson, MD, BS, PhD Department of Clinical Sciences Lund, Division of Child & Adolescent Psychiatry, Lund University and Office for Healthcare “Sund”, Child & Adolescent Psychiatry, Regional Inpatient Care, Emergency Department, Malmö Sweden
Kristian Hansson, MS Office for Healthcare “Sund”, Child & Adolescent Psychiatry, Regional Inpatient Care, Emergency Department, Malmö Sweden
 
6.45
Depression, Anxiety, Behavioral Symptoms, and Quality of Life in Children and Adolescents Diagnosed With Cancer
In-Jung Sohn, MD Yonsei University College of Medicine, Institute of Behavioral Science in Medicine, Seoul South Korea
Keun-Ah Cheon, MD, PhD Yonsei University College of Medicine, Institute of Behavioral Science in Medicine, Seoul South Korea
Nam-Wook Kim Yonsei University College of Medicine, Institute of Behavioral Science in Medicine, Seoul South Korea
Dong-Ho Song, MD, PhD Yosei University College of Medicine, Institute of Behavioral Science in Medicine, Seoul South Korea
 
6.46
Predictive Factors for Inpatient Aggression by Children and Adolescents
Drew H. Barzman, MD Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Kacey Appel, BS Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Douglas Mossman, MD University of Cincinnati, Cincinnati, OH
Michael T. Sorter, MD Cincinnati Children's Hospital Medical Center, Cincinnati, OH
 
6.47
Language Impairment Associated With Aggression in an Inpatient Child Population
Hunter M. Gibbs, MD University of Arkansas for Medical Sciences, Little Rock, AR
Khiela J. Holmes, PhD University of Arkansas for Medical Sciences, Little Rock, AR
April McMillin, MS University of Arkansas for Medical Sciences, Little Rock, AR
Molly Gathright, MD University of Arkansas for Medical Sciences, Little Rock, AR

See more of: New Research Poster
Copyright © 2015 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.